Quantum BioPharma Ltd. Interest Expense On Lease Liabilities
Quantum BioPharma Ltd. (QNTM) reported Interest Expense On Lease Liabilities of $19.06 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-31.
Discontinued › Expense Statement
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2023-03-31
CAD
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2019-12-31 | 15.26K CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2022-12-31 | $19.06K 20-F · filed 2023-03-31 |
| 2021-12-31 | $9.35K 20-F · filed 2023-03-31 |
| 2020-12-31 | $10.37K 20-F · filed 2022-03-31 |
| 2019-12-31 | $11.48K 40-F · filed 2021-03-17 |